Grown Rogue International (GRUSF) Change in Cash (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Change in Cash of $2.3 million for Q1 2026, down 31.03% year-over-year from $3.4 million in Q1 2025, and up 100.0% quarter-over-quarter from -$8411.9 billion in Q4 2025.
Grown Rogue International (GRUSF) Change in Cash (2009 - 2026) Analysis & Trends
Grown Rogue International's Change in Cash history runs 17 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- In Q1 2026, Change in Cash fell 31.03% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at -$8411.9 billion (down 8379814135.29% YoY), while the FY2025 annual figure was $6.5 million, up 442.05% from the prior year.
- Change in Cash for Q1 2026 stood at $2.3 million, up from -$8411.9 billion in the prior quarter.
- The five-year high for Change in Cash was $5.0 million in Q3 2023, with the low at -$8411.9 billion in Q4 2025.
- The 5-year median for Change in Cash is $390177.9 (2022), against an average of -$647.1 billion.
- The sharpest annual moves came in 2023 and 2025: Change in Cash jumped 262.1% in 2023, then tumbled 1292022234.5% in 2025.
- Grown Rogue International's Change in Cash stood at $390177.9 in 2022, then surged by 915.05% to $4.0 million in 2023, then sank by 116.44% to -$651061.9 in 2024, then sank by 1292022234.5% to -$8411.9 billion in 2025, then soared by 100.0% to $2.3 million in 2026.
- Business Quant data shows GRUSF's Change in Cash at $2.3 million in Q1 2026, -$8411.9 billion in Q4 2025, and -$199505.2 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Grown Rogue International | 123.27 Mn | 111.73 Mn | 5.37 Mn | -2.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.17 Mn |
| Mar 31, 2026 | 2.33 Mn |
| Dec 31, 2025 | -8,411.87 Bn |
| Jun 30, 2025 | -199,505.15 |
| Mar 31, 2025 | 3.38 Mn |
| Dec 31, 2024 | -651,061.93 |
| Sep 30, 2024 | -1.41 Mn |
| Jun 30, 2024 | -1.41 Mn |
| Mar 31, 2024 | 1.97 Mn |
| Oct 31, 2023 | 3.96 Mn |
| Jul 31, 2023 | 4.99 Mn |
| Apr 30, 2023 | 300,769.00 |
| Jan 31, 2023 | 1.41 Mn |
| Jan 31, 2022 | 390,177.86 |
| Oct 31, 2021 | 358.13 Bn |
| Jul 31, 2021 | -857.56 Bn |
| Apr 30, 2021 | 438,942.00 |
| Jan 31, 2021 | 1.06 Mn |
| Oct 31, 2020 | -373,564.00 |
| Jul 31, 2020 | -8,039.00 |